查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386501

腦腫瘤診斷市場報告：2030 年趨勢、預測與競爭分析

Brain Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

腦腫瘤診斷的趨勢和預測

預計到 2030 年，全球腦瘤診斷市場將達到 93 億美元，2024 年至 2030 年複合年成長率為 23.7%。這個市場的主要促進因素是腦腫瘤患者數量的增加、對腦腫瘤早期診斷的認知不斷提高以及與腦腫瘤細胞相關的藥物輸送系統的創新。全球腦瘤診斷市場前景廣闊，醫院、專科診所、診斷中心/研究機構、門診手術中心市場都有商機。

腦腫瘤診斷市場洞察

Lucintel 預測，由於生活方式、遺傳因素和診斷系統改進等病因趨勢，多形性膠質母細胞瘤將繼續成為最大的部分。

在同一市場中，由於腦腫瘤的增加、醫院基礎設施的改善以及癌症診斷投資和資金籌措的增加，醫院在預測期內預計將出現最高的成長。

由於研發活動的活性化和成像技術的改進，北美仍然是最大的市場。

本報告回答了 11 個關鍵問題：

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個區隔市場將以更快的速度成長？為什麼？
  • Q.3.哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要課題和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去五年發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章執行摘要

第2章全球腦腫瘤診斷市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球腦腫瘤診斷市場趨勢（2018-2023）與預測（2024-2030）
  • 依測試類型分類的全球腦腫瘤診斷市場
    • 影像檢查
    • 切片檢查
    • 腰椎穿刺
    • 分子檢測
    • 腦電圖測試
    • 其他
  • 依癌症類型分類的全球腦腫瘤診斷市場
    • 聽神經瘤
    • 星狀細胞瘤
    • 多形性膠質母細胞瘤
    • 腦膜瘤
    • 少突膠質細胞瘤
    • 其他
  • 依年齡層別分類的全球腦腫瘤診斷市場
    • 孩子
    • 成人
    • 老人
  • 依最終用途分類的全球腦腫瘤診斷市場
    • 醫院
    • 專科診所
    • 診斷中心和研究所
    • 門診手術中心
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球腦腫瘤診斷市場（依地區）
  • 北美腦腫瘤診斷市場
  • 歐洲腦腫瘤診斷市場
  • 亞太地區腦腫瘤診斷市場
  • 其他區域腦腫瘤診斷市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 依測試類型分類的全球腦腫瘤診斷市場成長機會
    • 依癌症類型分類的全球腦腫瘤診斷市場成長機會
    • 依年齡層別分類的全球腦腫瘤診斷市場成長機會
    • 全球腦腫瘤診斷市場最終用途的成長機會
    • 依地區分類的全球腦腫瘤診斷市場成長機會
  • 全球腦腫瘤診斷市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球腦腫瘤診斷市場的產能擴張
    • 全球腦腫瘤診斷市場的合併、收購與合資企業
    • 認證和許可

第7章主要企業概況

  • Thermo Fisher Scientific
  • Siemens Healthcare Diagnostics
  • Hologic
  • NantOmics
  • GE Healthcare
  • NIHON KOHDEN
  • Canon
  • FUJIFILM Holdings
簡介目錄

Brain Cancer Diagnostic Trends and Forecast

The future of the global brain cancer diagnostic market looks promising with opportunities in the hospital, specialty clinic, diagnostic center & research institute, ambulatory surgical center markets. The global brain cancer diagnostic market is expected to reach an estimated $9.3 billion by 2030 with a CAGR of 23.7% from 2024 to 2030. The major drivers for this market are the increasing cases of brain cancer, growing awareness towards early diagnosis for brain cancer, and innovations in drug delivery system related to brain cancer cells.

A more than 150-page report is developed to help in your business decisions.

Brain Cancer Diagnostic by Segment

The study includes a forecast for the global brain cancer diagnostic by test type, cancer type, age group, end use, and region.

Brain Cancer Diagnostic Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

  • Imaging Test
  • Biopsy
  • Lumber Puncture
  • Molecular Testing
  • Electroencephalography
  • Others

Brain Cancer Diagnostic Market by Cancer Type [Shipment Analysis by Value from 2018 to 2030]:

  • Acoustic Neuroma
  • Astrocytomas
  • Glioblastoma Multiforme
  • Meningiomas
  • Oligodendroglioma
  • Others

Brain Cancer Diagnostic Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:

  • Children
  • Adult
  • Geriatic

Brain Cancer Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers & Research Institutes
  • Ambulatory Surgical Centers
  • Others

Brain Cancer Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Brain Cancer Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies brain cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the brain cancer diagnostic companies profiled in this report include-

  • Thermo Fisher Scientific
  • Siemens Healthcare Diagnostics
  • Hologic
  • Nantomics
  • GE Healthcare
  • Nihon Kohden
  • Canon
  • Fujifilm Holdings

Brain Cancer Diagnostic Market Insights

Lucintel forecasts that glioblastoma multiforme will remain the largest segment due to the etiological trends of lifestyle, genetic factors, and improved diagnostic systems.

Within this market, hospitals is expected to witness highest growth over the forecast period due to increasing prevelance of brain cancer, improvement in the hospital infrastructure, and rising investments and funding in cancer daignostics.

North America will remain the largest segment due to increasing research and development activities and improved imaging techniques in the region.

Features of the Global Brain Cancer Diagnostic Market

Market Size Estimates: Brain cancer diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Brain cancer diagnostic market size by various segments, such as by test type, cancer type, age group, end use, and region in terms of ($B).

Regional Analysis: Brain cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different test types, cancer types, age groups, end uses, and regions for the brain cancer diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the brain cancer diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the brain cancer diagnostic market size?

Answer: The global brain cancer diagnostic market is expected to reach an estimated $9.3 billion by 2030.

Q.2 What is the growth forecast for brain cancer diagnostic market?

Answer: The global brain cancer diagnostic market is expected to grow with a CAGR of 23.7% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the brain cancer diagnostic market?

Answer: The major drivers for this market are the increasing cases of brain cancer, growing awareness towards early diagnosis for brain cancer, and innovations in drug delivery system related to brain cancer cells.

Q4. What are the major segments for brain cancer diagnostic market?

Answer: The future of the brain cancer diagnostic market looks promising with opportunities in the hospital, specialty clinic, diagnostic center & research institute, ambulatory surgical center markets.

Q5. Who are the key brain cancer diagnostic market companies?

Answer: Some of the key brain cancer diagnostic companies are as follows:

  • Thermo Fisher Scientific
  • Siemens Healthcare Diagnostics
  • Hologic
  • Nantomics
  • GE Healthcare
  • Nihon Kohden
  • Canon
  • Fujifilm Holdings

Q6. Which brain cancer diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that glioblastoma multiforme will remain the largest segment due to the etiological trends of lifestyle, genetic factors, and improved diagnostic systems.

Q7. In brain cancer diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment due to increasing research and development activities and improved imaging techniques in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the brain cancer diagnostic market by test type (imaging test, biopsy, lumber puncture, molecular testing, electroencephalography, and others), cancer type (acoustic neuroma, astrocytomas, glioblastoma multiforme, meningiomas, oligodendroglioma, and others), age group (children, adult, and geriatic), end use (hospitals, specialty clinics, diagnostic centers & research institutes, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Brain Cancer Diagnostic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Brain Cancer Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Brain Cancer Diagnostic Market by Test Type
    • 3.3.1: Imaging Test
    • 3.3.2: Biopsy
    • 3.3.3: Lumber Puncture
    • 3.3.4: Molecular Testing
    • 3.3.5: Electroencephalography
    • 3.3.6: Others
  • 3.4: Global Brain Cancer Diagnostic Market by Cancer Type
    • 3.4.1: Acoustic Neuroma
    • 3.4.2: Astrocytomas
    • 3.4.3: Glioblastoma Multiforme
    • 3.4.4: Meningiomas
    • 3.4.5: Oligodendroglioma
    • 3.4.6: Others
  • 3.5: Global Brain Cancer Diagnostic Market by Age Group
    • 3.5.1: Children
    • 3.5.2: Adult
    • 3.5.3: Geriatic
  • 3.6: Global Brain Cancer Diagnostic Market by End Use
    • 3.6.1: Hospitals
    • 3.6.2: Specialty Clinics
    • 3.6.3: Diagnostic Centers & Research Institutes
    • 3.6.4: Ambulatory Surgical Centers
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Brain Cancer Diagnostic Market by Region
  • 4.2: North American Brain Cancer Diagnostic Market
    • 4.2.2: North American Brain Cancer Diagnostic Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others
  • 4.3: European Brain Cancer Diagnostic Market
    • 4.3.1: European Brain Cancer Diagnostic Market by Cancer Type: Acoustic Neuroma, Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others
    • 4.3.2: European Brain Cancer Diagnostic Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others
  • 4.4: APAC Brain Cancer Diagnostic Market
    • 4.4.1: APAC Brain Cancer Diagnostic Market by Cancer Type: Acoustic Neuroma, Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others
    • 4.4.2: APAC Brain Cancer Diagnostic Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others
  • 4.5: ROW Brain Cancer Diagnostic Market
    • 4.5.1: ROW Brain Cancer Diagnostic Market by Cancer Type: Acoustic Neuroma, Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others
    • 4.5.2: ROW Brain Cancer Diagnostic Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Brain Cancer Diagnostic Market by Test Type
    • 6.1.2: Growth Opportunities for the Global Brain Cancer Diagnostic Market by Cancer Type
    • 6.1.3: Growth Opportunities for the Global Brain Cancer Diagnostic Market by Age Group
    • 6.1.4: Growth Opportunities for the Global Brain Cancer Diagnostic Market by End Use
    • 6.1.5: Growth Opportunities for the Global Brain Cancer Diagnostic Market by Region
  • 6.2: Emerging Trends in the Global Brain Cancer Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Brain Cancer Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Brain Cancer Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Siemens Healthcare Diagnostics
  • 7.3: Hologic
  • 7.4: NantOmics
  • 7.5: GE Healthcare
  • 7.6: NIHON KOHDEN
  • 7.7: Canon
  • 7.8: FUJIFILM Holdings